Clinical Trial

Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection

Name: Clinical Study on the Treatment of Refractory Rheumatoid Arthritis With UTAA91 Injection — clinical trial record (NCT06982547)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Early Phase 1

View on ClinicalTrials.gov →

Summary

This clinical trial is designed as a single - arm, open - label, single - center, investigator - initiated early - phase clinical study. The primary objective is to evaluate the safety of UTAA91 injection in treating subjects with refractory moderate - to - severe active rheumatoid arthritis.

Trial Details

NCT Number	NCT06982547
Lead Sponsor	PersonGen BioTherapeutics (Suzhou) Co., Ltd.
Conditions	Rheumatoid Arthritis (RA)
Enrollment	24 participants
Start Date	2025-06
Primary Completion	2027-12 (estimated)
Study Completion	2040-06 (estimated)
Updated on ClinicalTrials.gov	2025-05-21